The GPER agonist G-1 induces mitotic arrest and apoptosis in human vascular smooth muscle cells independent of GPER

Journal of Cellular Physiology

Volumn 230, Issue 4, 2015, Pages 885-895

  Gui, Yu ^a   Shi, Zhan ^b   Wang, Zengyong ^c   Li, Jing Jing ^c   Xu, Can ^c   Tian, Ruijuan ^c   Song, Xinxing ^c   Walsh, Michael P ^b   Li, Dong ^a   Gao, Jie ^a   Zheng, Xi Long ^b  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 [4 (6 BROMOBENZO[1,3]DIOXOL 5 YL) 3A,4,5,9B TETRAHYDRO 3H CYCLOPENTA[C]QUINOLIN 8 YL]ETHANONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BROXURIDINE; BUB1 RELATED PROTEIN; CASPASE 3; CASPASE 9; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; G PROTEIN COUPLED RECEPTOR 30; HISTONE H3; HORMONE RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TUBULIN; UNCLASSIFIED DRUG; 1-(4-(6-BROMOBENZO(1,3)DIOXOL-5-YL)-3A,4,5,9B-TETRAHYDRO-3H-CYCLOPENTA(C)QUINOLIN-8-YL)ETHANONE; CYCLOPENTANE DERIVATIVE; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; QUINOLINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DEPOLYMERIZATION; DNA CONTENT; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; M PHASE CELL CYCLE CHECKPOINT; MICROTUBULE; MITOSIS INDEX; MITOSIS INHIBITION; MITOSIS SPINDLE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; AGONISTS; CELL CULTURE; DRUG EFFECTS; METABOLISM; MITOSIS; PHOSPHORYLATION;

APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CYCLOPENTANES; ESTROGENS; HUMANS; MITOSIS; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; QUINOLINES; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84919742556     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24817     Document Type: Article

References (46)

1. Ahola TM, Purmonen S, Pennanen P, Zhuang YH, Tuohimaa P, Ylikomi T. 2002. Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells. Eur J Biochem 269:2485-2490.
2. Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, Lappano R, Pandey DP, Picard D, Mauro L, Ando S, Maggiolini M. 2008. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinology 149:3799-3808.
3. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Koveker G, Karsch KR. 1997. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96:636-645.
4. Benten WP, Stephan C, Lieberherr M, Wunderlich F. 2001. Estradiol signaling via sequestrable surface receptors. Endocrinology 142:1669-1677.
5. Blajeski AL, Phan VA, Kottke TJ, Kaufmann SH. 2002. G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells. J Clin Invest 110:91-99.
6. Blasko E, Haskell CA, Leung S, Gualtieri G, Halks-Miller M, Mahmoudi M, Dennis MK, Prossnitz ER, Karpus WJ, Horuk R. 2009. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J Neuroimmunol 214:67-77.
7. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER. 2006. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2:207-212.
8. Chan QK, Lam HM, Ng CF, Lee AY, Chan ES, Ng HK, Ho SM, Lau KM. 2010. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ 17:1511-1523.
9. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E. 1994. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci U S A 91:3964-3968.
10. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. 2009. In vivo effects of a GPR30 antagonist. Nat Chem Biol 5:421-427.
11. Donaldson MM, Tavares AA, Hagan IM, Nigg EA, Glover DM. 2001. The mitotic roles of Polo-like kinase. J Cell Sci 114:2357-2358.
12. Elenkov IJ, Wilder RL, Bakalov VK, Link AA, Dimitrov MA, Fisher S, Crane M, Kanik KS, Chrousos GP. 2001. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 86:4933-4938.
13. Farb A, Heller PF, Shroff S, Cheng L, Kolodgie FD, Carter AJ, Scott DS, Froehlich J, Virmani R. 2001. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104:473-479.
14. Filardo EJ, Quinn JA, Bland KI, Frackelton AR, Jr.. 2000. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660.
15. Filardo EJ, Quinn JA, Frackelton AR, Jr., Bland KI. 2002. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84.
16. Gui Y, Zheng XL. 2003. Epidermal growth factor induction of phenotype-dependent cell cycle arrest in vascular smooth muscle cells is through the mitogen-activated protein kinase pathway. J Biol Chem 278:53017-53025.
17. Gui Y, Zheng XL. 2006. 2-methoxyestradiol induces cell cycle arrest and mitotic cell apoptosis in human vascular smooth muscle cells. Hypertension 47:271-280.
18. Gundersen GG, Khawaja S, Bulinski JC. 1987. Postpolymerization detyrosination of alpha-tubulin: A mechanism for subcellular differentiation of microtubules. J Cell Biol 105:251-264.
19. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, Gao X, Mueller-Guerre L, Marjon NA, Gut A, Minotti R, Meyer MR, Amann K, Ammann E, Perez-Dominguez A, Genoni M, Clegg DJ, Dun NJ, Resta TC, Prossnitz ER, Barton M. 2009. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 104:288-291.
20. He YY, Cai B, Yang YX, Liu XL, Wan XP. 2009. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci 100:1051-1061.
21. Holm A, Baldetorp B, Olde B, Leeb-Lundberg LM, Nilsson BO. 2011. The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J Vasc Res 48:327-335.
22. Holm A, Grande PO, Luduena RF, Olde B, Prasad V, Leeb-Lundberg LM, Nilsson BO. 2012. The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner. Mol Cell Biochem 366:239-249.
23. Huang H, Hittle J, Zappacosta F, Annan RS, Hershko A, Yen TJ. 2008. Phosphorylation sites in BubR1 that regulate kinetochore attachment, tension, and mitotic exit. J Cell Biol 183:667-680.
24. Isensee J, Meoli L, Zazzu V, Nabzdyk C, Witt H, Soewarto D, Effertz K, Fuchs H, Gailus-Durner V, Busch D, Adler T, de Angelis MH, Irgang M, Otto C, Noppinger PR. 2009. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 150:1722-1730.
25. Islam MN, Iskander MN. 2004. Microtubulin binding sites as target for developing anticancer agents. Mini Rev Med Chem 4:1077-1104.
26. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. 1996. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56:816-825.
27. Li T, Inoue A, Lahti JM, Kidd VJ. 2004. Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development. Mol Cell Biol 24:3188-3197.
28. Li W, Lan Z, Wu H, Wu S, Meadows J, Chen J, Zhu V, Dai W. 1999. BUBR1 phosphorylation is regulated during mitotic checkpoint activation. Cell Growth Differ 10:769-775.
29. Li F, Yu X, Szynkarski CK, Meng C, Zhou B, Barhoumi R, White RE, Heaps CL, Stallone JN, Han G. 2013. Activation of GPER induces differentiation and inhibition of coronary artery smooth muscle cell proliferation. PloS One 8:e64771.
30. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC. 2009. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 150:3753-3758.
31. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D. 2009. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 28:523-532.
32. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. 2008. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 70:165-190.
33. Rao PN, Engelberg J. 1967. Structural specificity of estrogens in the induction of mitotic chromatid non-disjunction in HeLa cells. Exp Cell Res 48:71-81.
34. Seegers JC, Aveling ML, Van Aswegen CH, Cross M, Koch F, Joubert WS. 1989. The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J Steroid Biochem 32:797-809.
35. Sorger PK, Dobles M, Tournebize R, Hyman AA. 1997. Coupling cell division and cell death to microtubule dynamics. Curr Opin Cell Biol 9:807-814.
36. Takada Y, Kato C, Kondo S, Korenaga R, Ando J. 1997. Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem Biophys Res Commun 240:737-741.
37. Tan AL, Rida PC, Surana U. 2005. Essential tension and constructive destruction: the spindle checkpoint and its regulatory links with mitotic exit. Biochem J 386:1-13.
38. Thomas P, Pang Y, Filardo EJ, Dong J. 2005. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146:624-632.
39. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Ando S, Maggiolini M. 2006a. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 70:1414-1423.
40. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Ando S, Maggiolini M. 2006b. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 20:631-646.
41. Wang C, Lv X, He C, Hua G, Tsai MY, Davis JS. 2013. The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization. Cell Death Dis 4: e 869.
42. Wang C, Lv X, Jiang C, Davis JS. 2012. The putative G-protein coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian and breast cancer cells in a GPER-independent manner. Am J Transl Res 4:390-402.
43. Wang TH, Wang HS, Soong YK. 2000. Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together. Cancer 88:2619-2628.
44. Wheeler WJ, Hsu TC, Tousson A, Brinkley BR. 1987. Mitotic inhibition and chromosome displacement induced by estradiol in Chinese hamster cells. Cell Motil Cytoskeleton 7:235-247.
45. Wong OK, Fang G. 2007. Cdk1 phosphorylation of BubR1 controls spindle checkpoint arrest and Plk1-mediated formation of the 3F3/2 epitope. J Cell Biol 179:611-617.
46. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul PW. 2001. Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i). J Biol Chem 276:27071-27076.